Cargando…

Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma

Long non-coding RNAs (lncRNAs) have emerged as key regulators of cellular progress in lung adenocarcinoma. In this study, to identify cancer-related lncRNAs and genes, we screened for those lncRNAs that were differentially expressed in lung adenocarcinoma, which revealed LINC00628 overexpression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Shu-Feng, Zheng, Yue, Zhang, Ling, Wang, Ping, Niu, Chun-Mi, Wu, Tong, Tian, Qi, Yin, Xiao-Bo, Shi, Shan-Shan, Zheng, Lei, Gao, Li-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796683/ https://www.ncbi.nlm.nih.gov/pubmed/31557618 http://dx.doi.org/10.1016/j.omtn.2019.08.005

Ejemplares similares

LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC
por: Liu, Tingting, et al.
Publicado: (2022)

Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes
por: Zhang, Zi-Zhen, et al.
Publicado: (2016)

Long non‐coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation‐dependent repression of CDH1 promoter
por: Gao, Li‐Ming, et al.
Publicado: (2019)

The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
por: Xu, Xiaoliang, et al.
Publicado: (2019)

Dalai Lama
Publicado: (2020)

Dalaï-Lama
Publicado: (2020)

Lamas in loops
por: Lai, Eric C.
Publicado: (2003)

Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326
por: Zhang, Weiran, et al.
Publicado: (2023)

Dalai Lama at CERN
Publicado: (1983)

Visit of Dalay Lama
Publicado: (1983)

Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma
por: Wang, Lulin, et al.
Publicado: (2020)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

Long non-coding RNA KIKAT/LINC01061 as a novel epigenetic regulator that relocates KDM4A on chromatin and modulates viral reactivation
por: Yang, Wan-Shan, et al.
Publicado: (2021)

Dalai Lama comes to CERN
Publicado: (1983)

A Conversation with the Grand Lama
Publicado: (1889)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis
por: Chen, Ching-Yi, et al.
Publicado: (2020)

Factors Contributing to Leaving against Medical Advice (LAMA): A Consideration of the Patients’ Perspective
por: Pasay-an, Eddieson, et al.
Publicado: (2023)

Long non-coding RNA LCAL62 / LINC00261 is associated with lung adenocarcinoma prognosis
por: Dang, Ha X., et al.
Publicado: (2020)

LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1
por: Li, Yue, et al.
Publicado: (2022)

La sabiduría del Dalai Lama /
por: Dalai Lama XIV, 1935-
Publicado: (1999)

Le Dalaï Lama au CERN
Publicado: (1983)

The Dalai Lama on visit to CERN, 1983
Publicado: (1983)

Single Inhaler LABA/LAMA for COPD
por: Malerba, Mario, et al.
Publicado: (2019)

lamaGOET: an interface for quantum crystallography
por: Malaspina, Lorraine A., et al.
Publicado: (2021)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
por: Aziz, Mohamed Ismail Abdul, et al.
Publicado: (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
por: Singh, Dave, et al.
Publicado: (2019)

Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation
por: Lu, Huimin, et al.
Publicado: (2019)

Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription
por: Liu, Songsong, et al.
Publicado: (2020)

Da lama ao caos : Chico Science & Nação Zumbi /
por: Calábria, Lorena
Publicado: (2019)

CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy
por: Arockiaraj, Annie I., et al.
Publicado: (2023)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Clinical importance of long non-coding RNA LINC00460 expression in EGFR-mutant lung adenocarcinoma
por: Nakano, Yuta, et al.
Publicado: (2019)

Comparative genomic analyses highlight the contribution of pseudogenized protein-coding genes to human lincRNAs
por: Liu, Wan-Hsin, et al.
Publicado: (2017)

Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
por: Liang, Jinghui, et al.
Publicado: (2020)

To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer
por: Shen, Peng, et al.
Publicado: (2017)

Visit to CERN of his Holiness the Dalai Lama
por: CERN Press Office. Geneva
Publicado: (1983)

H.H. the Dalai Lama and Carlo Rubbia
por: CERN PhotoLab
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_4k3f8msj6p7h6cjkh8deudj837